InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,425.61
(
-0.15%
)
US TECH 100
19,140.80
(
0.38%
)
Dow Jones
38,516.16
(
-0.34%
)
Brent Oil
82.65
(
0.82%
)
Bitcoin
65,485.13
(
-1.91%
)
Post# of 81
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Sheep

Send PM Follow Ignore
Followers 114
Posts 6021
Boards Moderated 3
Alias Born 09/16/2009

Sheep

Re: None

Wednesday, 04/02/2014 11:28:00 AM

Wednesday, April 02, 2014 11:28:00 AM

Post# of 81
A little DD:

NDA is April 22, 2014
PDUFA is May 25th 2014 http://www.biopharmcatalyst.com/fda-calendar/

The company has 17 million in cash. See page 3: http://www.otcmarkets.com/financialReportViewer?symbol=QRXPY&id=116633


Even Better From Page 3

Both Aspen and Teva will assume responsibility for all regulatory and product launch costs as well as ongoing marketing and sales efforts with respect to the above strategic collaborations.



Full writeup on Seeking Alpha
http://seekingalpha.com/article/2102433-qrxpharma-pivotal-catalysts-present-significant-near-term-upside-potential

I took a starter position today.

Email: sheepery@gmail.com

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up